Medindia

X

Novo Nordisk's New Improved Insulin To Hit Markets by 2013

by VR Sreeraman on  December 24, 2010 at 12:26 PM Drug News   - G J E 4
Danish pharmaceutical company Novo Nordisk said Thursday it planned to put a new insulin product on the market by 2013 after tests showed advantages to the widely sold diabetes drug Lantus.
 Novo Nordisk's New Improved Insulin To Hit Markets by 2013
Novo Nordisk's New Improved Insulin To Hit Markets by 2013
Advertisement

"We believe that this ultra long-acting fourth-generation insulin will be a serious competitor to Lantus when it reaches the market in 2013," said Mike Rulis, a spokesman for the company which is a leader in treatments for diabetes.

Advertisement
Novo Nordisk on Thursday released results of studies it said showed that its product, Degludec, reduced the risk of dangerous drops in blood sugar levels during the night by 25 percent compared to Lantus, which is manufactured by the French company Sanofi-Aventis.

"Nocturnal hypoglycaemia -- episodes of too low blood sugar during the night -- is a major worry for many people with diabetes," Mads Krogsgaard Thomsen, Novo Nordisk's executive vice president and chief science officer, was quoted as saying in a statement.

According to the World Health Organisation, more than 220 million people worldwide have diabetes, which occurs when the body cannot produce insulin to regulate blood sugar levels or cannot use natural insulin effectively due to overweight and absence of sufficient exercise.

Source: AFP
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All